How big is the dry mouth market?
According to 6Wresearch internal database and industry insights, the dry mouth market was valued at approximately USD 3.1 billion in 2024 and is projected to reach USD 5.4 billion by 2031. The market is expected to grow at a CAGR of 8.2% during the forecast period.
This growth is driven by the rising prevalence of xerostomia caused by aging populations, medication side effects, autoimmune disorders like Sjögren syndrome, and increased awareness around oral health management.
Key Growth Factors of the Dry Mouth Market
- Increasing elderly population and chronic disease incidence
- Growing use of medications that induce dry mouth as a side effect
- Expanding consumer access to OTC saliva substitutes and mouthwashes
- Higher awareness of oral health and patient education
- Advancements in oral care product formulations
- Growth in dental visits and preventative care across developed and emerging economies
Dry Mouth Market Trends
Natural and plant-based oral care products are gaining popularity. Sugar-free and alcohol-free formulations are being preferred. Direct-to-consumer channels are expanding. Manufacturers are focusing on multi-symptom relief products combining hydration, breath freshening, and enamel protection.
Emerging Developments in the Dry Mouth Market
Product innovation is centered around long-acting mouth sprays and gels. Biotech firms are exploring saliva gland regeneration therapies. AI-driven diagnosis tools are emerging in dental clinics to detect xerostomia early. Subscription-based models are being introduced for dry mouth care packages.
Major Companies in the Dry Mouth Market
- GlaxoSmithKline plc
- Colgate-Palmolive Company
- Sunstar Group
- Johnson & Johnson
- Biotène (Haleon)
- OraCoat (OraHealth Corporation)
How big is the Dry Mouth Market : FAQ's
The dry mouth market is projected to reach USD 5.4 billion by 2031.
The dry mouth market is expected to grow at a CAGR of 8.2% during upcoming years.
Mouthwashes, lozenges, gels, chewing gums, and sprays are commonly used for symptom relief.
End-users include geriatric patients, individuals on long-term medications, and those with autoimmune conditions like Sjögren syndrome.
Asia-Pacific and Latin America are witnessing rapid growth due to increasing healthcare access and oral health awareness.
Challenges are low patient awareness in developing regions, lack of curative treatments, and limited reimbursement for OTC products.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com